These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 470710)

  • 1. Cryoprecipitate lyophilized in single donor units for treatment of haemophiliacs.
    Margolis J; Rhoades P
    Med J Aust; 1979 Jun; 1(11):523-4. PubMed ID: 470710
    [No Abstract]   [Full Text] [Related]  

  • 2. Prepooled cryoprecipitate for treatment of hemophilia A.
    Menitove JE; Spero JA; Richards WA; Lewis JH; Montgomery RR; Gill JC; Hasiba U; Wheeler DV; Sherwin JA; Russell-Vaskov S; Marlar RA; Maxwell NG; Aster RH
    Transfusion; 1983; 23(3):265-7. PubMed ID: 6407160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors.
    Evensen SA; Ulstrup J; Skaug K; Frøland SS; Glomstein A; Rollag H
    Eur J Haematol; 1987 Jul; 39(1):44-8. PubMed ID: 3115823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freeze dried cryoprecipitate: a clinical evaluation.
    Hambley H; Davidson JF; Walker ID; Small M; Prentice CR
    J Clin Pathol; 1983 May; 36(5):574-6. PubMed ID: 6404949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
    Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P
    Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Use and misuse of cryoprecipitate.
    Hensley MJ
    N Engl J Med; 1975 Jun; 292(24):1299. PubMed ID: 1128599
    [No Abstract]   [Full Text] [Related]  

  • 7. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 8. Lyophilized cryoprecipitate for children with hemophilia A.
    Nuchprayoon I; Sahasittiwat S; Kittikalayawong A; Chantanakajornfung A
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S293-7. PubMed ID: 12188426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haptoglobin level in haemophiliacs after administration of pooled cold precipitated antihaemophilic globulin. Preliminary report.
    Veselý V; Kulich V
    Haematologia (Budap); 1976; 10(3-4):379-81. PubMed ID: 1028672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of a heat treated antihaemophilic cryoprecipitate.
    Skjønsberg OH; Gravem K; Kierulf P; Godal HC
    Thromb Res; 1987 Mar; 45(5):625-34. PubMed ID: 3109063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of lyophilized cryoprecipitate in hemophilia A.
    Chuansumrit A; Isarangkura P; Chantanakajornfung A; Kuhathong K; Pintadit P; Jitpraphai C; Hathirat P; Nuchprayoon C
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S69-73. PubMed ID: 10730521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of heat treatment on FVIII:C recovery from freeze dried cryoprecipitate.
    Benny AG; Ockelford PA; Johns AS; Scott RH; Woodfield DG; Berry EW
    J Clin Pathol; 1988 Sep; 41(9):945-7. PubMed ID: 3142936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of management of patients with haemophilia.
    Carter F; Forbes CD; MacFarlane JD; Prentice CR
    Br Med J; 1976 Aug; 2(6033):465-7. PubMed ID: 953611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of freeze-dried plasma in the management of bleeding in a child with hemophilia in Djibouti].
    Maurin O; Boulesteix G; Eve O; Bertani A; Martinaud C; Kaiser E
    Ann Fr Anesth Reanim; 2012 May; 31(5):491-2. PubMed ID: 22464160
    [No Abstract]   [Full Text] [Related]  

  • 15. High-yield method of production of freeze-dried purified factor VIII by blood banks.
    Smit Sibinga CT; Welbergen H; Das PC; Griffin B
    Lancet; 1981 Aug; 2(8244):449-50. PubMed ID: 6115205
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose requirement for replacement therapy in hemophilia A.
    Allain JP
    Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambulatory treatment of hemorrhagic incidents in hemophiliacs with cryoprecipitate].
    Lisichkov T; Angelova Ts
    Vutr Boles; 1973; 12(3):96-9. PubMed ID: 4543117
    [No Abstract]   [Full Text] [Related]  

  • 18. Clotting factor concentrates for resistant haemophilia.
    Bloom AL
    Br J Haematol; 1978 Sep; 40(1):21-7. PubMed ID: 361064
    [No Abstract]   [Full Text] [Related]  

  • 19. Minimum effective dose of intermediate factor-VIII concentrate in haemophiliacs on home therapy.
    Stirling ML; Prescott RJ
    Lancet; 1979 Apr; 1(8120):813-4. PubMed ID: 86051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic value of cryoprecipitate in hemophilia A].
    Lopaciuk S; Szczepański M; Klenowska Z; Daszyński J; Pawelski S
    Pol Tyg Lek; 1969 Jun; 24(22):829-32. PubMed ID: 4895749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.